Total submissions: 24
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000074986 | SCV000108202 | likely benign | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% in specific ethnic group |
Gene |
RCV000115430 | SCV000149339 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-07 | criteria provided, single submitter | clinical testing | The variant is found in HEREDICANCER,BR-OV-HEREDIC,COLO-HEREDIC panel(s). |
Ambry Genetics | RCV000115430 | SCV000184313 | benign | Hereditary cancer-predisposing syndrome | 2015-06-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001081385 | SCV000262375 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000074986 | SCV000430982 | likely benign | Lynch syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000121569 | SCV000592669 | benign | not specified | 2017-05-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000115430 | SCV000685486 | benign | Hereditary cancer-predisposing syndrome | 2015-02-19 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587315 | SCV000695913 | benign | not provided | 2016-03-21 | criteria provided, single submitter | clinical testing | Variant summary: The c.4068_4071dupGATT (legacy name c.4065_4066insTTGA) variant results in a termination codon only two amino acids before the normal stop codon, thus the mutated protein may still retain its function, which was supported by one functional study (Martinez_2010). One in-silico tool predicts damaging outcome for this variant. This variant is found in 272/8626 control chromosomes in East Asian population (5 homozygotes) at a frequency of 0.0315, which is about 221 times of the maximal expected frequency of a pathogenic allele (0.0001421), suggesting this variant is benign. In addition, multiple clinical laboratories/reputable databases classified this variant as benign/likely benign. Taken together, this variant was classified as benign. |
Prevention |
RCV000587315 | SCV000805903 | likely benign | not provided | 2017-03-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV003228794 | SCV000837938 | benign | Hereditary nonpolyposis colon cancer | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000121569 | SCV000888287 | benign | not specified | 2021-03-11 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000121569 | SCV002070936 | benign | not specified | 2019-04-20 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000115430 | SCV002536316 | benign | Hereditary cancer-predisposing syndrome | 2020-06-10 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000121569 | SCV002552386 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149727 | SCV003838334 | benign | Breast and/or ovarian cancer | 2022-02-07 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315590 | SCV004016000 | likely benign | Lynch syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121569 | SCV000085765 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
3DMed Clinical Laboratory Inc | RCV000677891 | SCV000804052 | likely benign | Sigmoid colon cancer | 2017-05-15 | no assertion criteria provided | clinical testing | |
Ding PR Lab, |
RCV001093695 | SCV001250879 | uncertain significance | Lynch syndrome 1 | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000587315 | SCV001742036 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000587315 | SCV001800573 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000587315 | SCV001922852 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000587315 | SCV001969050 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000587315 | SCV001977735 | likely benign | not provided | no assertion criteria provided | clinical testing |